Skip to Content

Pfizer 25 LLN (Lorbrena 25 mg)

Generic Name: lorlatinib

Pill with imprint Pfizer 25 LLN is Tan, Round and has been identified as Lorbrena 25 mg. It is supplied by Pfizer Inc..

Lorbrena is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. Lorbrena 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Pfizer 25 LLN

Lorbrena 25 mg Pfizer 25 LLN

Lorbrena

Generic Name
lorlatinib
Imprint
Pfizer 25 LLN
Strength
25 mg
Color
Tan
Shape
Round
Availability
Prescription only
Drug Class
Multikinase inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pfizer Inc.
National Drug Code (NDC)
00069-0227

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.